FDA Surveys Teens on 'Real Cost' of Smoking Ads Impact
Published Date: 5/13/2026
Notice
Summary
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 1 costs, 2 mixed.
Longitudinal Youth Survey Recruiting
FDA is extending the ExPECTT Cohort 3 study that surveys U.S. youth about tobacco. The study began in February 2023, targets youth ages 11-17 at baseline (with a supplemental social-media sample of ages 14-20), and includes a baseline plus up to eight follow-up surveys conducted about every 6-9 months; up to 14,053 youth may be surveyed at each follow-up wave.
Participant Time Burden and No Monetary Costs
FDA estimates the total respondent burden for the study extension at 59,799 hours. Individual study tasks include a youth survey of 0.50 hours (30 minutes) per response and household recruitment materials taking about 0.05 hours (9 minutes); FDA states there are no capital or operating and maintenance costs for respondents.
Parental Permission Waiver for 14+ Youth
FDA received an institutional review board waiver of parental permission for youth aged 14 and older, so parental permission is not required for those participants. Parental permission remains required for younger youth and for certain recruitment and recontact activities.
Removal of Gender Identity Questions
To comply with Executive Order 14168, FDA will not assess or examine gender or gender identity in this study. The survey includes one sexual orientation item and one sex item: 'Are you female or male?'.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13047 — Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-13346 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products
The FDA is updating how it collects info about Medication Guides—those important leaflets that come with some prescription drugs to keep patients safe. This affects drug makers who must follow new rules about what info to include and how to share it. Comments on these changes are open until July 31, 2026, and the update aims to keep patients informed without adding extra costs.
2026-13140 — Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation
The FDA is officially putting the monitor for opioid-induced oxygen problems into a safer, easier-to-manage category called Class II. This change helps make sure the device works well and is safe, while also speeding up patient access to this important tech. The new rules took effect on June 30, 2026, and could lower costs and delays for companies making these monitors.
2026-13139 — Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis
The FDA is officially classifying the skin patch that treats excessive sweating (hyperhidrosis) as a Class II device, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps patients get access to this cool new treatment faster and safer, starting June 30, 2026. Companies making these patches will find it easier and less costly to bring their products to market.
2026-13006 — Determination of Regulatory Review Period for Purposes of Patent Extension; VYALEV
The FDA has officially set the review period for the drug VYALEV, which helps the company extend its patent protection. This means the patent clock can be paused, giving the drug maker more time to sell VYALEV exclusively. If anyone thinks the dates are wrong or the company wasn’t diligent, they can speak up by late 2026.
2026-13005 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; New Animal Drugs for Minor Use and Minor Species
The FDA is asking for public feedback on their plan to keep collecting info about new animal drugs for rare uses and less common species. This affects drug makers who want special approval and incentives for these unique animal medicines. Comments are open until July 29, 2026, and the process helps keep these important drugs safe and available without extra costs.
Previous / Next Documents
Previous: 2026-09447 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important health research grant applications. These meetings protect private info and trade secrets while deciding which projects get funding. Researchers applying for grants and the NIH community should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Next: 2026-09449 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; State Authorization
The Department of Education is asking to keep collecting info from states and schools without changing the current process. This affects private groups and government agencies who provide education, and they have until June 12, 2026, to share their thoughts. The paperwork won’t cost extra money but takes about 2,700 hours total each year to complete.